136 related articles for article (PubMed ID: 10362643)
1. CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones.
Xiao ZL; Chen Q; Amaral J; Biancani P; Jensen RT; Behar J
Am J Physiol; 1999 Jun; 276(6):G1401-7. PubMed ID: 10362643
[TBL] [Abstract][Full Text] [Related]
2. Role of caveolae in the pathogenesis of cholesterol-induced gallbladder muscle hypomotility.
Xiao Z; Schmitz F; Pricolo VE; Biancani P; Behar J
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1641-9. PubMed ID: 17307729
[TBL] [Abstract][Full Text] [Related]
3. Defect of receptor-G protein coupling in human gallbladder with cholesterol stones.
Xiao ZL; Chen Q; Amaral J; Biancani P; Behar J
Am J Physiol Gastrointest Liver Physiol; 2000 Feb; 278(2):G251-8. PubMed ID: 10666049
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cholecystokinin receptors on the human gallbladder.
Tokunaga Y; Cox KL; Coleman R; Concepcion W; Nakazato P; Esquivel CO
Surgery; 1993 Feb; 113(2):155-62. PubMed ID: 7679224
[TBL] [Abstract][Full Text] [Related]
5. Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity.
Chen Q; Amaral J; Biancani P; Behar J
Gastroenterology; 1999 Mar; 116(3):678-85. PubMed ID: 10029627
[TBL] [Abstract][Full Text] [Related]
6. Inositol trisphosphate restores impaired human gallbladder motility associated with cholesterol stones.
Behar J; Rhim BY; Thompson W; Biancani P
Gastroenterology; 1993 Feb; 104(2):563-8. PubMed ID: 8425698
[TBL] [Abstract][Full Text] [Related]
7. Different pathways mediate cholecystokinin actions in cholelithiasis.
Chen Q; De Petris G; Yu P; Amaral J; Biancani P; Behar J
Am J Physiol; 1997 Apr; 272(4 Pt 1):G838-44. PubMed ID: 9142916
[TBL] [Abstract][Full Text] [Related]
8. Gallbladder muscle dysfunction in patients with chronic acalculous disease.
Amaral J; Xiao ZL; Chen Q; Yu P; Biancani P; Behar J
Gastroenterology; 2001 Feb; 120(2):506-11. PubMed ID: 11159891
[TBL] [Abstract][Full Text] [Related]
9. Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones.
Yu P; Chen Q; Harnett KM; Amaral J; Biancani P; Behar J
Am J Physiol; 1995 Nov; 269(5 Pt 1):G659-65. PubMed ID: 7491956
[TBL] [Abstract][Full Text] [Related]
10. Gallbladder relaxation in patients with pigment and cholesterol stones.
Chen Q; Amaral J; Oh S; Biancani P; Behar J
Gastroenterology; 1997 Sep; 113(3):930-7. PubMed ID: 9287986
[TBL] [Abstract][Full Text] [Related]
11. DNA synthesis index: higher for human gallbladders with cholesterol gallstones than with pigment gallstones.
Lamote J; Putz P; Francois M; Willems G
J Natl Cancer Inst; 1983 Sep; 71(3):449-53. PubMed ID: 6577219
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin.
Kano M; Shoda J; Satoh S; Kobayashi M; Matsuzaki Y; Abei M; Tanaka N
J Lab Clin Med; 2002 May; 139(5):285-94. PubMed ID: 12032489
[TBL] [Abstract][Full Text] [Related]
13. Effects of cholesterol on CCK-1 receptors and caveolin-3 proteins recycling in human gallbladder muscle.
Cong P; Pricolo V; Biancani P; Behar J
Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G742-50. PubMed ID: 20558763
[TBL] [Abstract][Full Text] [Related]
14. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
Wang HH; Portincasa P; Wang DQ
Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
[TBL] [Abstract][Full Text] [Related]
15. Central and peripheral cholecystokinin receptors in chickens differ from those in mammals.
Rodríguez-Sinovas A; Fernández AG; Goñalons E
Regul Pept; 1995 Dec; 60(1):47-54. PubMed ID: 8747783
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscle.
Morton MF; Harper EA; Tavares IA; Shankley NP
Br J Pharmacol; 2002 Jul; 136(6):873-82. PubMed ID: 12110612
[TBL] [Abstract][Full Text] [Related]
17. [In vitro contractility of the musculature of human gallbladders with and without gallstones--relevance of the prostaglandin system for CCK regulated motoricity].
Schulz M; Hanisch E; Güldütüna S
Z Gastroenterol; 1993 Jun; 31(6):376-87. PubMed ID: 8212754
[TBL] [Abstract][Full Text] [Related]
18. Mucin content in gallbladders with brown pigment stones or combination stones with a brown periphery.
Sheen PC; Lee KT; Liu YE
Digestion; 1998; 59(6):660-4. PubMed ID: 9813390
[TBL] [Abstract][Full Text] [Related]
19. Gallbladder contraction in patients with pigment and cholesterol stones.
Behar J; Lee KY; Thompson WR; Biancani P
Gastroenterology; 1989 Dec; 97(6):1479-84. PubMed ID: 2583414
[TBL] [Abstract][Full Text] [Related]
20. Direct contractile response of isolated gallbladder smooth muscle cells to cholecystokinin in patients with gallstones.
Chijiiwa K; Yamasaki T; Chijiiwa Y
J Surg Res; 1994 May; 56(5):434-8. PubMed ID: 8170143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
